Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Event Details


Better Target Validation for Drug Discovery with CRISPR/Cas9

Add this event to your calendar: iCal   Google Calendar

Who should attend?

Academic & pharmaceutical researchers in drug discovery, including those who are interested in: Target validation with in vitro models CRISPR/Cas9 technology to provide further validation to de-risk potential druggable targets


Better target validation is a key driver of better productivity in drug discovery. The RNA-guided nucleases, exemplified by Cas9, represent a powerful new approach to understanding gene function and, in principle, to reveal the next generation of therapeutic targets. But how well does this technology work in practice? 




Fridha Bonilla

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.